The problem was not only side effects
Most premature-ejaculation treatment discussions focus on whether dapoxetine works.
That is not the only useful question.
The more revealing question is whether men keep using it.
A 2-year prospective observational study found that dapoxetine discontinuation was common. The surprising part was not a classic SSRI withdrawal pattern. The authors reported that no SSRI withdrawal syndromes were noted. Instead, men often stopped because of cost and frustration that treatment was needed every time adequate sexual function was desired. (PMC)
That makes Priligy dapoxetine discontinuation no withdrawal syndrome a more interesting topic than ordinary “does Priligy work?” searches.
It shows the difference between pharmacology and real life.
Why dapoxetine is not like daily SSRIs
Dapoxetine belongs to the SSRI family, but it was developed for on-demand use in premature ejaculation rather than daily antidepressant therapy.
Its pharmacokinetic profile helps explain why. A review describes dapoxetine as rapidly absorbed, with a short initial half-life of about 1.3–1.4 hours and rapid elimination with minimal accumulation even after repeated dosing. (PubMed)
That is part of what made dapoxetine suitable for sexual medicine.
Traditional SSRIs can delay ejaculation, but they are usually taken daily and may bring chronic sexual side effects, mood-related concerns, and withdrawal issues when stopped abruptly. Dapoxetine was designed for a narrower and more timed purpose.
The withdrawal question was studied directly
This matters because many patients hear “SSRI” and immediately think of dependence, tapering, or withdrawal.
Dapoxetine is different enough that withdrawal symptoms were specifically evaluated in premature-ejaculation trials. A review noted that dapoxetine was the only SSRI for which discontinuation symptoms had been systematically assessed in a PE population; in one international study, discontinuation-syndrome rates were low and similar across dapoxetine and placebo groups. (PMC)
That does not make the drug risk-free.
It means the common reason for stopping may not be withdrawal. It may be the mismatch between patient expectations and the reality of on-demand treatment.
The expectation problem
A man may expect a medication to “fix” PE.
Priligy works differently. It is not curative. It is event-based. The user must plan timing, tolerate side effects, pay for repeated use, and accept that the benefit may vary between sexual encounters.
That can become tiring.
In the real-world discontinuation study, disappointment that treatment was required each time was a major reason for stopping. (ScienceDirect)
This is a practical problem, not just a medical one.
A drug can be clinically effective and still fail as a long-term behavior pattern if the patient dislikes the process of using it.
The practical takeaway
Priligy’s overlooked lesson is that “on-demand” does not automatically mean easier.
For some men, it is convenient. For others, it adds planning, cost, uncertainty, and pressure. The absence of a strong withdrawal signal does not solve those issues.
A better treatment conversation should include more than dose and timing. It should ask:
Is the PE lifelong or acquired?
Is erectile dysfunction also present?
Is anxiety, prostatitis, thyroid disease, or relationship stress involved?
Does the patient want event-based medication, behavioral therapy, topical anesthetic options, or a broader sexual-health plan?
Priligy may help delay ejaculation.
But long-term success depends on whether the treatment model fits the patient’s actual life.
Disclaimer
This article is for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Dapoxetine or any medication for premature ejaculation should be used only under the guidance of a qualified healthcare professional.
References
Park HJ, Park NC, Kim TN, et al. Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study. Sexual Medicine, 2017. (PMC)
McMahon CG. Efficacy of Dapoxetine in the Treatment of Premature Ejaculation. (PMC)
Owen RT. Dapoxetine: a novel treatment for premature ejaculation. (PubMed)
Sangkum P, et al. Dapoxetine and the treatment of premature ejaculation. (PMC)
